
The newest urology products and services from US Urology, Cook Medical, Abbott Laboratories, the Medical Collaboration Network, the Agency for Healthcare Research and Quality, the AUA Foundation, and Trophikos, LLC.

The newest urology products and services from US Urology, Cook Medical, Abbott Laboratories, the Medical Collaboration Network, the Agency for Healthcare Research and Quality, the AUA Foundation, and Trophikos, LLC.

A team at the University of Washington School of Medicine and Applied Physics Lab, Seattle, is refining prototype technology that should allow extracorporeal ultrasound to image and, more importantly, move stones in a kidney as if they were being nudged gently by a pool cue.

Those of us who are not employed by a hospital or other entity remain small business men/women, and therefore need to be as attentive to the business aspect of our practices as we are to the clinical care we offer our patients.

Repeat injections of onabotulinumtoxinA (Botox) over the long term are showing value in patients with interstitial cystitis.

The investigational selective beta3-adrenoceptor agonist mirabegron effectively improves symptoms of overactive bladder and is very safe and well tolerated.

An organization's mission is more than its day-to-day activities. Writing a new mission statement can be a refreshing opportunity to step away from the busywork and refocus on what matters most.

Our commitment to our patients must be sustained. As a result, LESS is in everyone's future in one form or another.

After seeing physicians in Maine ask legislators to delay a bill limiting medical liability, speculation is that because doctors who have joined large groups or hospital practices have fewer concerns related to running a business-eg, meeting payroll, hiring staff, malpractice premiums, and meeting overhead-their priorities might be shifting.

Robotic pyeloplasty demonstrated several operative and outcome advantages over the laparoscopic technique in patients with ureteropelvic junction (UPJ) obstruction.

Adding vibrotactile feedback to robotic minimally invasive surgery can increase awareness of tool actions and surgeons' perceived ability to concentrate.

Urologists at Cleveland Clinic have undertaken a pilot program involving modification of a commercial electronic medical record (EMR) system to facilitate clinical research and clinical practice outcomes analysis in a way that overcomes the obstacles presented by the record-keeping technology.

Urologists want Medicare to be run efficiently and be easy for patients to navigate, regardless of whether it's run by the government or private industry.

Daniel P. Petrylak, MD, explains the role of new first- and second-line prostate cancer therapies, how they address previously unmet needs, and their associated side effects.

Before jumping on the gold bandwagon, it is important to understand the market factors that impact gold pricing, and how this unique commodity may or may not fit into your overall investment portfolio.

Laparoendoscopic single-site surgery (LESS) has evolved to the point that a broad range of urologic procedures can be performed effectively and safely by applying different techniques.

Physician organizations nationwide, including the AUA, have united in opposition to many provisions of a plan by the Centers for Medicare & Medicaid Services to sell Medicare claims data to qualified businesses that would generate public reports rating physician performance in each episode of care.

Analyses of data from a large series of men undergoing microdissection testicular sperm extraction (mTESE) showed that among patients who had no sperm found in the OR, 7% had sperm identified following tissue digestion and extensive searching in the laboratory.


Utilization trends for minimally invasive treatment of prostate cancer appear to be similar across sites of service, a recent study indicates.

Seasonal variations in kidney stone incidence appear to be reflected in Google search engine queries, according to researchers at the University of California, San Francisco.

Long-term use of degarelix (Firmagon), a gonadotropin-releasing hormone therapy approved for the treatment of advanced prostate cancer in both Europe and the United States, continues to be effective and well tolerated beyond 3 years, according a recent study.

New guidelines from the American Academy of Pediatrics do not recommend routine use of voiding cystourethrography (VCUG) after the first urinary tract infection in febrile infants and children aged 2 to 24 months.

About half of all office-based U.S. physicians-including urologists-belong to practices that employ non-physician providers, according to a government report. Primary care physicians are more likely to work with them than medical and surgical specialists.

In men with erectile dysfunction, 65% are unable to have an orgasm and 58% have problems with ejaculation, say researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center.

The FDA recently approved onabotulinumtoxinA (Botox) injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition (eg, spinal cord injury, multiple sclerosis) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

Passive management is an investment strategy that attempts to replicate the returns of an index or benchmark by owning the same assets, in the same proportions, as the underlying index. Active managers attempt to outperform the market through the art of stock picking and market timing.

Physical therapists have responded to the high costs of physical therapy for CP/CPPS (often not covered by insurance) by helping patients learn to massage their own pelvic floor muscle trigger points with internal massage tools. Now, there's evidence that this at-home, self-treatment approach works.

New analyses of data from the phase III study establishing the superiority of denosumab (XGEVA) to zoledronic acid (Zometa) for preventing skeletal-related events in men with bone metastases from castrate-resistant prostate cancer provide further evidence of the therapeutic value of the novel bone-targeted agent.

An embolization technique employing 100-?m or 200-?m polyvinyl beads delivered through the femoral artery and into prostatic arteries to block the latter and shrink prostate volume in men with BPH produces short- and mid-term results equivalent to transurethral resection of the prostate.

The high selectivity of the alpha-blocker silodosin (Rapaflo) may be the reason for its success in treating CP/CPPS in a recent trial.